Last reviewed · How we verify

NCT03612024

Bernese Next of Kin Survey Following Organ Donation Request

Completed Last updated 31 August 2018
What this trial tests

trial testing questionnaire in Organ Donation in 117 participants. Completed in 24 July 2018.

Timeline
1 March 2018
Primary endpoint
1 July 2018
24 July 2018

Quick facts

Lead sponsorInsel Gruppe AG, University Hospital Bern
StatusCompleted
Study typeOBSERVATIONAL
Enrollment117
Start date1 March 2018
Primary completion1 July 2018
Estimated completion24 July 2018
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Insel Gruppe AG, University Hospital Bern

Who can join

Eligibility, any sex, with Organ Donation or Next of Kin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

6 to 18 months after organ donation request a next of kin survey using a standardized questionnaire was conducted.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Organ donation in the ICU - a survey on next of kin response in two Swiss academic centres.
    Nebiker M, Bloch A, Fedakar P, Christen L, et al · · 2021 · cited 2× · PMID 34161597 · DOI 10.4414/smw.2021.20515

Verify or expand the search:

Other trials of questionnaire

Trials testing the same drug.

Other recruiting trials for Organ Donation

Currently open trials in the same condition.

Other Insel Gruppe AG, University Hospital Bern trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03612024.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing